Mana Capital Acquisition Corp, trading under the ticker MAAQ on Nasdaq, is a blank-check company sponsored by Mana Capital Sponsor LLC that completed its IPO in 2021 with a focus on the healthcare sector. The SPAC entered into a business combination agreement with Cardio Diagnostics, Inc., an AI-powered cardiovascular disease diagnostics company, and filed an 8-K with the SEC on May 31, 2022, reflecting a material development in that de-SPAC process. Cardio Diagnostics Holdings, Inc. is the resulting combined entity, operating in the clinical-stage diagnostics and precision medicine space. Investors tracking the full filing history, deal timeline, and current status of MAAQ can sign up for SpacDesk to access comprehensive SPAC data in one place.